Tag: knee bursitis market top players

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Knee Bursitis Market Size Outlook: How Fast Will Revenue Grow Through 2030?

The market for knee bursitis treatments experienced robust expansion recently, projecting a rise from $2.86 billion in 2025 to $3.06 billion in 2026, reflecting a compound annual growth rate of 7.3%. This historical growth trajectory is underpinned by several key factors: a surge in the occurrence of knee injuries and conditions resulting from repetitive strain, heightened engagement in athletic pursuits and physical fitness activities, the consistent utilization of diagnostic imaging for musculoskeletal issues, an increasing segment of the population entering older age groups with accompanying joint ailments, and the widespread accessibility of anti-inflammatory pharmaceuticals.

The market for knee bursitis treatments is poised for significant expansion over the coming years, projected to reach a value of $3.92 billion by 2030, with a compound annual growth rate of 6.4%. This anticipated growth is fueled by several key factors, including a heightened demand for less invasive medical procedures, a greater emphasis on identifying and preventing the condition early, a rise in the utilization of physiotherapy services, the expansion of facilities dedicated to orthopedic care, and enhanced accessibility to diagnostic imaging in developing economies. Dominating trends expected during this period are a growing inclination towards managing knee bursitis without surgery, the increased reliance on imaging technologies for precise diagnoses, a greater uptake of physical therapy and rehabilitation programs, the proliferation of outpatient and conservative treatment strategies, and heightened patient awareness concerning prompt management of knee injuries.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16460&type=smp

Knee Bursitis Market Expansion Drivers: What Is Shaping Future Growth?

The escalating incidence of skeletal ailments is anticipated to stimulate the expansion of the knee bursitis market in the foreseeable future. These bone-related conditions, including but not limited to osteoporosis, arthritis, and bone cancer, negatively impact the skeletal system’s structure, resilience, and functionality. A confluence of factors, such as an aging global population, predominantly sedentary lifestyles, suboptimal nutritional intake, and environmental shifts, contributes to the growing prevalence of these diseases. Conditions like osteoarthritis and rheumatoid arthritis can precipitate knee bursitis by inducing inflammation and excessive stress on the knee’s bursa. This inflammatory response subsequently leads to discomfort, swelling, and diminished joint mobility. To illustrate, data from Healthy Bones Australia, a non-profit entity dedicated to osteoporosis prevention and bone health awareness, indicated in October 2024 that approximately 6.2 million Australians aged 50 and above, representing about 67% of that demographic, suffered from compromised bone health. Projections suggest a substantial increase, with an estimated 7.7 million individuals expected to face osteopenia or osteoporosis by 2033. Consequently, the heightened prevalence of bone-related issues is a significant catalyst for the knee bursitis market’s growth.

The expanding demographic of individuals with diabetes is poised to invigorate the knee bursitis market’s progression

Knee Bursitis Market Segmentation And Category Breakdown

The knee bursitis market covered in this report is segmented –

1) By Diagnosis: Clinical Evaluation, Imaging Techniques, Laboratory And Procedural Tests, Differential Diagnosis Support

2) By Treatment: Medication, Therapy, Surgery, Other Treatments

3) By End User: Hospitals And Clinics, Diagnostic Centers, Research Centers, Academic Institutes, Other End Users

Subsegments:

1) By Clinical Evaluation: Medical History Assessment, Physical Examination

2) By Imaging Techniques: X-Ray, Ultrasound, Magnetic Resonance Imaging

3) By Laboratory And Procedural Tests: Bursa Fluid Aspiration, Blood Tests

4) By Differential Diagnosis Support: Infection Exclusion Tests, Inflammatory Marker Assessment, Trauma-Related Assessment

Knee Bursitis Market Competitive Analysis Of Major Industry Participants

Major companies operating in the knee bursitis market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Eli Lilly and Company, AbbVie Inc., Johnson & Johnson, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Stryker Corporation, Zimmer Biomet Holdings Inc., Arthrex Inc., Smith & Nephew plc, Medtronic plc, Exactech Inc., Conformis Inc., Bioventus LLC, Horizon Therapeutics plc, Amneal Pharmaceuticals Inc.

Access The Complete Knee Bursitis Market Report:

https://www.thebusinessresearchcompany.com/report/knee-bursitis-global-market-report

Knee Bursitis Market Largest Region By Revenue And Market Share

North Americawas the largest region in the knee bursitis market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the knee bursitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Knee Bursitis Market Size Outlook: How Fast Will Revenue Grow Through 2030?

The market for knee bursitis treatments experienced robust expansion recently, projecting a rise from $2.86 billion in 2025 to $3.06 billion in 2026, reflecting a compound annual growth rate of 7.3%. This historical growth trajectory is underpinned by several key factors: a surge in the occurrence of knee injuries and conditions resulting from repetitive strain, heightened engagement in athletic pursuits and physical fitness activities, the consistent utilization of diagnostic imaging for musculoskeletal issues, an increasing segment of the population entering older age groups with accompanying joint ailments, and the widespread accessibility of anti-inflammatory pharmaceuticals.

The market for knee bursitis treatments is poised for significant expansion over the coming years, projected to reach a value of $3.92 billion by 2030, with a compound annual growth rate of 6.4%. This anticipated growth is fueled by several key factors, including a heightened demand for less invasive medical procedures, a greater emphasis on identifying and preventing the condition early, a rise in the utilization of physiotherapy services, the expansion of facilities dedicated to orthopedic care, and enhanced accessibility to diagnostic imaging in developing economies. Dominating trends expected during this period are a growing inclination towards managing knee bursitis without surgery, the increased reliance on imaging technologies for precise diagnoses, a greater uptake of physical therapy and rehabilitation programs, the proliferation of outpatient and conservative treatment strategies, and heightened patient awareness concerning prompt management of knee injuries.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16460&type=smp

Knee Bursitis Market Expansion Drivers: What Is Shaping Future Growth?

The escalating incidence of skeletal ailments is anticipated to stimulate the expansion of the knee bursitis market in the foreseeable future. These bone-related conditions, including but not limited to osteoporosis, arthritis, and bone cancer, negatively impact the skeletal system’s structure, resilience, and functionality. A confluence of factors, such as an aging global population, predominantly sedentary lifestyles, suboptimal nutritional intake, and environmental shifts, contributes to the growing prevalence of these diseases. Conditions like osteoarthritis and rheumatoid arthritis can precipitate knee bursitis by inducing inflammation and excessive stress on the knee’s bursa. This inflammatory response subsequently leads to discomfort, swelling, and diminished joint mobility. To illustrate, data from Healthy Bones Australia, a non-profit entity dedicated to osteoporosis prevention and bone health awareness, indicated in October 2024 that approximately 6.2 million Australians aged 50 and above, representing about 67% of that demographic, suffered from compromised bone health. Projections suggest a substantial increase, with an estimated 7.7 million individuals expected to face osteopenia or osteoporosis by 2033. Consequently, the heightened prevalence of bone-related issues is a significant catalyst for the knee bursitis market’s growth.

The expanding demographic of individuals with diabetes is poised to invigorate the knee bursitis market’s progression

Knee Bursitis Market Segmentation And Category Breakdown

The knee bursitis market covered in this report is segmented –

1) By Diagnosis: Clinical Evaluation, Imaging Techniques, Laboratory And Procedural Tests, Differential Diagnosis Support

2) By Treatment: Medication, Therapy, Surgery, Other Treatments

3) By End User: Hospitals And Clinics, Diagnostic Centers, Research Centers, Academic Institutes, Other End Users

Subsegments:

1) By Clinical Evaluation: Medical History Assessment, Physical Examination

2) By Imaging Techniques: X-Ray, Ultrasound, Magnetic Resonance Imaging

3) By Laboratory And Procedural Tests: Bursa Fluid Aspiration, Blood Tests

4) By Differential Diagnosis Support: Infection Exclusion Tests, Inflammatory Marker Assessment, Trauma-Related Assessment

Knee Bursitis Market Competitive Analysis Of Major Industry Participants

Major companies operating in the knee bursitis market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Eli Lilly and Company, AbbVie Inc., Johnson & Johnson, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Stryker Corporation, Zimmer Biomet Holdings Inc., Arthrex Inc., Smith & Nephew plc, Medtronic plc, Exactech Inc., Conformis Inc., Bioventus LLC, Horizon Therapeutics plc, Amneal Pharmaceuticals Inc.

Access The Complete Knee Bursitis Market Report:

https://www.thebusinessresearchcompany.com/report/knee-bursitis-global-market-report

Knee Bursitis Market Largest Region By Revenue And Market Share

North Americawas the largest region in the knee bursitis market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the knee bursitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Knee Bursitis Market Size Outlook: How Fast Will Revenue Grow Through 2030?

The market for knee bursitis treatments experienced robust expansion recently, projecting a rise from $2.86 billion in 2025 to $3.06 billion in 2026, reflecting a compound annual growth rate of 7.3%. This historical growth trajectory is underpinned by several key factors: a surge in the occurrence of knee injuries and conditions resulting from repetitive strain, heightened engagement in athletic pursuits and physical fitness activities, the consistent utilization of diagnostic imaging for musculoskeletal issues, an increasing segment of the population entering older age groups with accompanying joint ailments, and the widespread accessibility of anti-inflammatory pharmaceuticals.

The market for knee bursitis treatments is poised for significant expansion over the coming years, projected to reach a value of $3.92 billion by 2030, with a compound annual growth rate of 6.4%. This anticipated growth is fueled by several key factors, including a heightened demand for less invasive medical procedures, a greater emphasis on identifying and preventing the condition early, a rise in the utilization of physiotherapy services, the expansion of facilities dedicated to orthopedic care, and enhanced accessibility to diagnostic imaging in developing economies. Dominating trends expected during this period are a growing inclination towards managing knee bursitis without surgery, the increased reliance on imaging technologies for precise diagnoses, a greater uptake of physical therapy and rehabilitation programs, the proliferation of outpatient and conservative treatment strategies, and heightened patient awareness concerning prompt management of knee injuries.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16460&type=smp

Knee Bursitis Market Expansion Drivers: What Is Shaping Future Growth?

The escalating incidence of skeletal ailments is anticipated to stimulate the expansion of the knee bursitis market in the foreseeable future. These bone-related conditions, including but not limited to osteoporosis, arthritis, and bone cancer, negatively impact the skeletal system’s structure, resilience, and functionality. A confluence of factors, such as an aging global population, predominantly sedentary lifestyles, suboptimal nutritional intake, and environmental shifts, contributes to the growing prevalence of these diseases. Conditions like osteoarthritis and rheumatoid arthritis can precipitate knee bursitis by inducing inflammation and excessive stress on the knee’s bursa. This inflammatory response subsequently leads to discomfort, swelling, and diminished joint mobility. To illustrate, data from Healthy Bones Australia, a non-profit entity dedicated to osteoporosis prevention and bone health awareness, indicated in October 2024 that approximately 6.2 million Australians aged 50 and above, representing about 67% of that demographic, suffered from compromised bone health. Projections suggest a substantial increase, with an estimated 7.7 million individuals expected to face osteopenia or osteoporosis by 2033. Consequently, the heightened prevalence of bone-related issues is a significant catalyst for the knee bursitis market’s growth.

The expanding demographic of individuals with diabetes is poised to invigorate the knee bursitis market’s progression

Knee Bursitis Market Segmentation And Category Breakdown

The knee bursitis market covered in this report is segmented –

1) By Diagnosis: Clinical Evaluation, Imaging Techniques, Laboratory And Procedural Tests, Differential Diagnosis Support

2) By Treatment: Medication, Therapy, Surgery, Other Treatments

3) By End User: Hospitals And Clinics, Diagnostic Centers, Research Centers, Academic Institutes, Other End Users

Subsegments:

1) By Clinical Evaluation: Medical History Assessment, Physical Examination

2) By Imaging Techniques: X-Ray, Ultrasound, Magnetic Resonance Imaging

3) By Laboratory And Procedural Tests: Bursa Fluid Aspiration, Blood Tests

4) By Differential Diagnosis Support: Infection Exclusion Tests, Inflammatory Marker Assessment, Trauma-Related Assessment

Knee Bursitis Market Competitive Analysis Of Major Industry Participants

Major companies operating in the knee bursitis market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Eli Lilly and Company, AbbVie Inc., Johnson & Johnson, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Stryker Corporation, Zimmer Biomet Holdings Inc., Arthrex Inc., Smith & Nephew plc, Medtronic plc, Exactech Inc., Conformis Inc., Bioventus LLC, Horizon Therapeutics plc, Amneal Pharmaceuticals Inc.

Access The Complete Knee Bursitis Market Report:

https://www.thebusinessresearchcompany.com/report/knee-bursitis-global-market-report

Knee Bursitis Market Largest Region By Revenue And Market Share

North Americawas the largest region in the knee bursitis market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the knee bursitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Knee Bursitis Market Change Between 2026 And 2030?

The knee bursitis market size has shown robust expansion in recent years. It is anticipated to increase from $2.86 billion in 2025 to $3.06 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.3%. The historical market growth can be attributed to factors such as an escalating incidence of knee injuries and repetitive stress conditions, increased engagement in sports and physical activities, the well-established use of imaging in diagnosing musculoskeletal conditions, a growing aging population experiencing joint disorders, and the widespread availability of anti-inflammatory medications.

The market size for knee bursitis is projected to experience robust expansion in the coming years. Its valuation is anticipated to reach $3.92 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.4%. This growth during the forecast period can be attributed to an increasing demand for minimally invasive treatments, a growing emphasis on early diagnosis and prevention, the rising adoption of physiotherapy services, the expansion of orthopedic care infrastructure, and improved access to diagnostic imaging in emerging markets. Significant trends for the forecast period include a growing preference for non-surgical knee bursitis management, an increasing reliance on imaging for accurate diagnosis, a rising adoption of physical therapy and rehabilitation, the expansion of outpatient and conservative treatment approaches, and enhanced patient awareness of early knee injury care.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16460&type=smp

What Major Growth Factors Are Impacting The Knee Bursitis Market?

The rising incidence of bone-related ailments is anticipated to drive the expansion of the knee bursitis market in the coming years. These bone conditions include diseases like osteoporosis, arthritis, and bone cancer, all of which compromise the skeletal system’s structure, strength, and overall function. The growing frequency of bone-related diseases is linked to elements such as an aging demographic, inactive habits, inadequate nutrition, and evolving environmental conditions. Specifically, bone conditions such as osteoarthritis and rheumatoid arthritis contribute to knee bursitis by inducing inflammation and undue strain on the knee bursa. This inflammation then manifests as pain, swelling, and diminished joint movement. For example, in October 2024, Healthy Bones Australia, an Australia-based national nonprofit organization dedicated to osteoporosis prevention and bone health awareness, reported that approximately 6.2 million Australians aged 50 and over, representing about 67% of this age group, were experiencing poor bone health. This figure is predicted to increase substantially, reaching around 7.7 million individuals with osteopenia or osteoporosis by 2033. Consequently, the increasing occurrence of bone-related diseases is fueling the growth of the knee bursitis market.

Which Segment Groups Define The Knee Bursitis Market Landscape?

The knee bursitis market covered in this report is segmented –

1) By Diagnosis: Clinical Evaluation, Imaging Techniques, Laboratory And Procedural Tests, Differential Diagnosis Support

2) By Treatment: Medication, Therapy, Surgery, Other Treatments

3) By End User: Hospitals And Clinics, Diagnostic Centers, Research Centers, Academic Institutes, Other End Users

Subsegments:

1) By Clinical Evaluation: Medical History Assessment, Physical Examination

2) By Imaging Techniques: X-Ray, Ultrasound, Magnetic Resonance Imaging

3) By Laboratory And Procedural Tests: Bursa Fluid Aspiration, Blood Tests

4) By Differential Diagnosis Support: Infection Exclusion Tests, Inflammatory Marker Assessment, Trauma-Related Assessment

Who Are The Prominent Players Across The Knee Bursitis Market?

Major companies operating in the knee bursitis market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Eli Lilly and Company, AbbVie Inc., Johnson & Johnson, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Stryker Corporation, Zimmer Biomet Holdings Inc., Arthrex Inc., Smith & Nephew plc, Medtronic plc, Exactech Inc., Conformis Inc., Bioventus LLC, Horizon Therapeutics plc, Amneal Pharmaceuticals Inc.

Access The Complete Knee Bursitis Market Report:

https://www.thebusinessresearchcompany.com/report/knee-bursitis-global-market-report

Which Region Is The Dominant Market In The Knee Bursitis Market?

North America was the largest region in the knee bursitis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the knee bursitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Knee Bursitis Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=16460&type=smp

Browse Through More Reports Similar to the Global Knee Bursitis Market 2026, By The Business Research Company

Gouty Arthritis Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report

Osteoarthritis Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report

Knee Implants Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/knee-implants-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Knee Bursitis Market In 2026, And How Will Its Value Evolve By 2030?

The market for knee bursitis treatments has experienced robust expansion over recent years. This market is projected to expand from $2.86 billion in 2025 to $3.06 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 7.3%. Historically, this growth has been driven by factors such as a rise in knee injuries and conditions related to repetitive stress, increased involvement in sports and physical activities, the well-established application of imaging techniques in musculoskeletal diagnosis, an expanding elderly demographic experiencing joint disorders, and the accessibility of anti-inflammatory medications.

The knee bursitis market is anticipated to experience substantial expansion over the upcoming years. It is projected to reach $3.92 billion by 2030, showing a compound annual growth rate (CAGR) of 6.4%. This projected growth during the forecast period is due to factors like an increasing demand for minimally invasive treatments, a heightened focus on early diagnosis and prevention, the growing acceptance of physiotherapy services, the expansion of orthopedic care infrastructure, and improved access to diagnostic imaging in emerging markets. Significant trends for this period include a rising preference for non-surgical knee bursitis management, more frequent use of imaging for accurate diagnosis, a surge in the adoption of physical therapy and rehabilitation, the broadening of outpatient and conservative treatment approaches, and enhanced patient awareness regarding early knee injury care.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16460&type=smp

Which Key Drivers Are Affecting The Knee Bursitis Market Development?

The expanding incidence of bone-related ailments is projected to boost the expansion of the Knee Bursitis Market in the future. These conditions, including osteoporosis, arthritis, and bone cancer, compromise the skeletal system’s structure, strength, and functionality. The rising occurrence of such diseases is linked to factors like an aging demographic, inactive routines, inadequate nutrition, and shifts in environmental conditions. Specifically, bone conditions such as osteoarthritis and rheumatoid arthritis can trigger knee bursitis by inducing inflammation and undue stress on the knee bursa, leading to discomfort, swelling, and diminished joint movement. An example of this trend is seen in Australia; as per Healthy Bones Australia, a national nonprofit organization dedicated to osteoporosis prevention and bone health awareness, an estimated 6.2 million Australians aged 50 and over, representing about 67% of this demographic, experienced poor bone health in October 2024. This figure is expected to climb considerably, potentially reaching approximately 7.7 million people with osteopenia or osteoporosis by 2033. Consequently, the growing prevalence of bone-related diseases is propelling the growth of the Knee Bursitis Market.

How Are Different Segments Classified In The Knee Bursitis Market Segment Analysis?

The knee bursitis market covered in this report is segmented –

1) By Diagnosis: Clinical Evaluation, Imaging Techniques, Laboratory And Procedural Tests, Differential Diagnosis Support

2) By Treatment: Medication, Therapy, Surgery, Other Treatments

3) By End User: Hospitals And Clinics, Diagnostic Centers, Research Centers, Academic Institutes, Other End Users

Subsegments:

1) By Clinical Evaluation: Medical History Assessment, Physical Examination

2) By Imaging Techniques: X-Ray, Ultrasound, Magnetic Resonance Imaging

3) By Laboratory And Procedural Tests: Bursa Fluid Aspiration, Blood Tests

4) By Differential Diagnosis Support: Infection Exclusion Tests, Inflammatory Marker Assessment, Trauma-Related Assessment

Who Are The Companies Driving Activity In The Knee Bursitis Market?

Major companies operating in the knee bursitis market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Eli Lilly and Company, AbbVie Inc., Johnson & Johnson, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Stryker Corporation, Zimmer Biomet Holdings Inc., Arthrex Inc., Smith & Nephew plc, Medtronic plc, Exactech Inc., Conformis Inc., Bioventus LLC, Horizon Therapeutics plc, Amneal Pharmaceuticals Inc.

Get The Full Knee Bursitis Market Report:

https://www.thebusinessresearchcompany.com/report/knee-bursitis-global-market-report

Which Region Has The Greatest Market Share In The Knee Bursitis Market?

North America was the largest region in the knee bursitis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the knee bursitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Knee Bursitis Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/knee-bursitis-global-market-report

Browse Through More Reports Similar to the Global Knee Bursitis Market 2026, By The Business Research Company

Gouty Arthritis Market Report 2026

https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report

Osteoarthritis Market Report

https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report

Knee Implants Market Report

https://www.thebusinessresearchcompany.com/report/knee-implants-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Knee Bursitis Market Across 2026–2030?

The knee bursitis market size has shown significant expansion in recent years. This market is set to increase from $2.86 billion in 2025 to $3.06 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.3%. Several factors contributed to its historical growth, including a rise in the occurrence of knee injuries and repetitive stress conditions, increased involvement in sports and physical activities, the well-established application of imaging in diagnosing musculoskeletal issues, an expanding aging population experiencing joint disorders, and the accessibility of anti-inflammatory medications.

The market for knee bursitis is projected to experience robust expansion over the coming years. This market is anticipated to reach $3.92 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.4%. Factors contributing to this growth during the projection period include an escalating demand for less invasive therapies, a heightened emphasis on prompt diagnosis and preventative measures, increased utilization of physiotherapy services, the development of orthopedic care facilities, and enhanced availability of diagnostic imaging in developing regions. Key trends expected during the forecast period encompass a growing inclination towards non-surgical management of knee bursitis, a rise in the application of imaging for precise diagnosis, wider acceptance of physical therapy and rehabilitation, an increase in outpatient and conservative treatment methods, and better patient understanding of early knee injury care.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16460&type=smp

Which Market Drivers Are Supporting The Expansion Of The Knee Bursitis Market?

The expanding occurrence of bone-related ailments is anticipated to boost the expansion of the knee bursitis market in the future. These conditions, which include osteoporosis, arthritis, and bone cancer, impact the skeletal system’s structure, strength, and overall function. The growing incidence of bone-related diseases stems from factors such as older populations, inactive lifestyles, inadequate nutrition, and shifts in the environment. Specifically, conditions like osteoarthritis and rheumatoid arthritis can trigger knee bursitis by inducing inflammation and undue stress on the knee bursa, leading to discomfort, swelling, and diminished joint mobility. An example demonstrating this trend is data from October 2024 by Healthy Bones Australia, an Australia-based national nonprofit organization dedicated to osteoporosis prevention and bone health awareness, which estimated that 6.2 million Australians aged 50 and over, representing approximately 67% of this demographic, suffered from poor bone health. This figure is predicted to climb significantly to around 7.7 million people living with osteopenia or osteoporosis by 2033. Consequently, the rising prevalence of bone-related conditions is fueling the growth of the knee bursitis market. The expanding number of individuals with diabetes is projected to drive the future growth of the knee bursitis market. Diabetes is a long-term ailment characterized by the body’s inability to adequately manage blood sugar levels, either from inadequate insulin generation or inefficient insulin utilization. The escalation in diabetes diagnoses can be linked to factors like inactive routines, poor eating habits, and inherited genetic tendencies. Those with diabetes are susceptible to developing knee bursitis due to inflammation resulting from sustained pressure on the knees, compromised immune system function, or other diabetes-related complications. For example, in June 2024, a report from the National Health Service (NHS), a UK-based public health organization, indicated that the count of individuals registered with pre-diabetes rose to 3,615,330 in 2023, an 18% increase from 3,065,825 in 2022. Thus, the growing diabetic population is a key factor propelling the expansion of the knee bursitis market.

What Segmentation Levels Are Considered In The Knee Bursitis Market?

The knee bursitis market covered in this report is segmented –

1) By Diagnosis: Clinical Evaluation, Imaging Techniques, Laboratory And Procedural Tests, Differential Diagnosis Support

2) By Treatment: Medication, Therapy, Surgery, Other Treatments

3) By End User: Hospitals And Clinics, Diagnostic Centers, Research Centers, Academic Institutes, Other End Users

Subsegments:

1) By Clinical Evaluation: Medical History Assessment, Physical Examination

2) By Imaging Techniques: X-Ray, Ultrasound, Magnetic Resonance Imaging

3) By Laboratory And Procedural Tests: Bursa Fluid Aspiration, Blood Tests

4) By Differential Diagnosis Support: Infection Exclusion Tests, Inflammatory Marker Assessment, Trauma-Related Assessment

Which Leading Firms Are Contributing To The Growth Of The Knee Bursitis Market?

Major companies operating in the knee bursitis market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Eli Lilly and Company, AbbVie Inc., Johnson & Johnson, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Stryker Corporation, Zimmer Biomet Holdings Inc., Arthrex Inc., Smith & Nephew plc, Medtronic plc, Exactech Inc., Conformis Inc., Bioventus LLC, Horizon Therapeutics plc, Amneal Pharmaceuticals Inc.

Read the full knee bursitis market report here:

https://www.thebusinessresearchcompany.com/report/knee-bursitis-global-market-report

How Is The Knee Bursitis Market Distributed Across Key Geographic Regions?

North America was the largest region in the knee bursitis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the knee bursitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Knee Bursitis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16460&type=smp

Browse Through More Reports Similar to the Global Knee Bursitis Market 2026, By The Business Research Company

Gouty Arthritis Global Market Report

https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report

Osteoarthritis Global Market Report

https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report

Knee Implants Global Market Report

https://www.thebusinessresearchcompany.com/report/knee-implants-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model